The patients with symptomatic aspiration episodes.
Conditions
Interventions
administration of imidapril 2.5mg per day for 4 weeks.
Sponsors
National Hospital Organization Disaster Medical Cente
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Those who visit our hospital with the episode of symptomatic aspiration. No change of drug administration prior to the entry.
Exclusion criteria
Exclusion criteria: # Those who experienced the disease exacerbation within 4 weeks prior to the entry. # Those who are under-control of the basic diseases. # Those who experienced the thoraco-abdominal surgery within 4 weeks prior to the entry # Those who are pregnant or during the lactation. # Those whom the doctors in charge would consider that the patients are unapropriate to be recruited in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incident rate of naso-pharyngeal reflux in the patients with aspiration and the impact of imidapril hydrochloride on the improvement of aspiration and naso-pgaryngeal reflux is asessed after 4weeks of administration of the drug. | — |
Countries
Japan
Contacts
Public ContactMitsuhiro Kamimura
National Hospital Organization Disaster Medical Center Department of Pulmonology
Outcome results
None listed